查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715738

软骨修復/再生市场按修復技术、目标部位、材料类型、来源类型、应用和最终用户划分—2025-2030 年全球预测

Cartilage Repair/Cartilage Regeneration Market by Repair Technique, Targeted Site, Material Type, Source Type, Application, End-Users - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

软骨修復/再生市场预计到 2024 年将达到 19.1 亿美元，到 2025 年将达到 20.9 亿美元，到 2030 年将达到 34.8 亿美元，复合年增长率为 10.49%。

主要市场统计数据
基准年2024年 19.1亿美元
预计2025年 20.9亿美元
预测年份 2030 34.8亿美元
复合年增长率（%） 10.49%

近年来，随着创新方法和深化科学见解的融合，软骨修復和再生领域发生了重大变化。这个充满活力的领域位于生物医学工程和临床应用的交叉点，已经从传统方法发展到更个人化的再生策略。研究人员和从业人员越来越注重解决传统修復技术的局限性，而技术进步正在引导临床实践走向自然再生不仅可实现而且可靠的未来。

软骨相关损伤和退化性疾病的日益普及正在改变这一现状，迫使相关人员重新审视现有的调查方法并投资于尖端研究。临床试验和新兴技术开始描绘出一幅乐观的景象，再生技术已被证明能够彻底解决患者护理中长期存在的挑战。在对有效解决方案的迫切需求的推动下，行业专家正在为软骨修復的新时代铺平道路，以实现更持久、更自然的癒合。

本介绍为深入了解重新定义该市场的变革性变化、提供主要市场驱动因素全面细分的详细细分细分洞察以及影响当前趋势的全球、区域和企业力量奠定了基础。随着市场扩大和新科学方法的整合，跟上决定软骨再生未来方向的不断发展的趋势将至关重要。

软骨修復领域的变化

随着新技术和新方法打破长期确立的范式，软骨修復和再生领域正在转变。向生物学方法的转变是由干细胞研究、组织工程和新型支架材料的进步所推动的，这些进步共同试图更紧密地模仿自然癒合过程。这一演变的特点是与传统的外科手术介入有显着不同，转而采用微创再生手术，以加快恢復时间并改善患者的整体治疗效果。

自体软骨细胞移植和微骨折技术等创新治疗方法为更先进的软骨再生方法奠定了基础。此外，组织工程中基于细胞和基于支架的技术的整合为临床医生提供了治疗复杂软骨损伤的更好方法。随着研究不断检验这些新方法，人们越来越一致地认为，向生物再生的转变不仅仅是一种渐进的改进，而且是该领域的巨大飞跃。

治疗方法的重组也体现在市场投资、监管改革和不断提高的患者期望。这种范式转变迫使产业相关人员进行多学科合作，并对研发进行策略性投资，以确保创新治疗方法在临床上得到有效采用。治疗方法的演变凸显了现代方法的变革潜力，为产业带来了新的发展动力，并为改善生活品质提供了光明前景。

市场区隔洞察推动市场创新

仔细观察市场区隔可以发现影响软骨修復和再生领域的复杂层面。它首先根据修復技术对市场进行细分，包括自体软骨细胞移植、软骨成形术、微骨折、镶嵌成形术、骨软骨自体移植以及日益突出的基于干细胞的软骨再生，并进一步区分成体干细胞和胚胎干细胞。此外，组织工程已细分为基于细胞和基于支架的技术，从而可以更细緻地了解临床干预措施。

此外，按目标部位细分显示软骨修復针对特定的解剖部位，例如踝关节、肘关节、髋关节、膝关节和肩关节，每个部位都有不同的生理和动态需求。材料类型是区分天然和合成生物材料的另一个重要分割参数。几丁聚醣、胶原蛋白和透明质酸等天然材料与聚乙二醇和聚乳酸等合成材料进行比较，强调生物相容性和功能耐久性之间的平衡。

此外，按来源类型进行市场细分，区分同种异体和自体，在针对特定患者的治疗策略中发挥重要作用。应用进一步细分为弹性软骨修復、纤维软骨修復和透明软骨修復，突显成功结果所需的临床特异性。最后，最终用户细分确定了关键客户，例如门诊手术中心、医院和整形外科诊所，每个客户都会影响产品开发和市场进入策略。这些多层次的见解为复杂的软骨修復生态系统中的针对性创新和策略规划提供了基础。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 增加参与体育运动和体育活动的人数
      • 全球骨关节炎盛行率不断上升
      • 提高对软骨相关疾病的认识并改善诊断技术
    • 限制因素
      • 软骨修復和再生治疗费用不断上涨
    • 机会
      • 利用3D生物列印技术创建客製化软骨植入
      • 政府对先进医学研究和开发的支持性资金和奖励
    • 任务
      • 与某些软骨修復手术相关的术后併发症和长期副作用的风险
  • 市场区隔分析
    • 修復技术：自体软骨细胞移植术在软骨缺损治疗中越来越受欢迎
    • 最终用户：将纤维软骨修復扩展到半月软骨和椎间盘
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章 软骨修復/软骨再生市场（依修復技术）

  • 自体软骨细胞移植术（ACI）
  • 软骨成形术
  • 微骨折
  • 马赛克塑料
  • 骨软骨自体移植（OAT）
  • 利用干细胞进行软骨再生
    • 成体干细胞
    • 胚胎干细胞
  • 组织工程
    • 基于细胞的技术
    • 基于支架的技术

第七章软骨修復/再生市场目标区域

  • 踝关节软骨
  • 手肘软骨
  • 髋关节软骨
  • 膝关节软骨
  • 肩膀软骨

第 8 章 软骨修復/再生市场（依材料类型）

  • 天然生医材料
    • 几丁聚醣基
    • 胶原蛋白蛋白基
    • 玻尿酸基
  • 合成生医材料
    • 聚乙二醇（PEG）
    • 聚乳酸（PLA）

第九章 软骨修復/再生市场（依来源类型）

  • 同种异体
  • 自体移植

第 10 章 软骨修復/软骨再生市场：依应用

  • 弹性软骨修復
  • 纤维软骨修復
  • 透明软骨修復

第 11 章 软骨修復/再生市场（按最终用户）

  • 门诊手术中心
  • 医院
  • 整形外科诊所

12.美洲软骨修復/再生市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太地区软骨修復/再生市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

14. 欧洲、中东和非洲软骨修復/再生市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Anika Therapeutics Inc.
  • Arthrex, Inc.
  • B. Braun SE
  • BioTissue, Inc.
  • Bioventus
  • Collagen Solutions Ltd.
  • CollPlant Biotechnologies Ltd.
  • CONMED Corporation
  • Episurf Medical AB
  • Geistlich Pharma AG
  • Integra LifeSciences Corporation
  • Isto Biologics Inc
  • Johnson & Johnson Services, Inc.
  • Kolon TissueGene, Inc.
  • MEDIPOST Co., Ltd.
  • Mesoblast Limited
  • Ocugen, Inc.
  • Orthocell Ltd.
  • Regrow Biosciences Pvt Ltd.
  • RTI Surgical, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-4103B31E00C5

The Cartilage Repair/Cartilage Regeneration Market was valued at USD 1.91 billion in 2024 and is projected to grow to USD 2.09 billion in 2025, with a CAGR of 10.49%, reaching USD 3.48 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.91 billion
Estimated Year [2025] USD 2.09 billion
Forecast Year [2030] USD 3.48 billion
CAGR (%) 10.49%

In recent years, the field of cartilage repair and regeneration has seen significant evolution, driven by the integration of innovative methodologies and deepening scientific insights. This dynamic sector, positioned at the intersection of biomedical engineering and clinical application, has evolved from conventional approaches to more personalized and regenerative strategies. Researchers and practitioners have increasingly focused on addressing the limitations of traditional repair techniques, while technological advancements are steering clinical practices towards a future where natural regeneration is not only achievable but also reliable.

The growing prevalence of cartilage-related injuries and degenerative conditions has transformed the landscape, compelling stakeholders to reexamine existing methodologies and invest in cutting-edge research. Clinical trials and emerging technologies have begun to paint an optimistic picture of what is possible, with regenerative techniques proving to be transformative in addressing long-standing challenges in patient care. Driven by an urgent need for effective solutions, industry experts are paving the way for a new era in cartilage repair that promises longer-lasting and more natural healing outcomes.

This introduction sets the stage for a thorough examination of the transformative shifts that have redefined this market, the detailed segmentation insights that offer a comprehensive breakdown of key market drivers, and the global, regional, and corporate forces influencing current trends. As the market expands and integrates novel scientific approaches, it becomes crucial to continuously engage with the evolving trends that dictate future directions in cartilage regeneration.

Transformative Shifts in the Landscape of Cartilage Repair

The cartilage repair and regeneration landscape is undergoing transformative changes as new technologies and methodologies disrupt long-established paradigms. The shift towards biologically driven approaches has been fueled by advancements in stem cell research, tissue engineering, and novel scaffold materials, which collectively strive to mimic the natural healing process more closely. This evolution is marked by a significant departure from traditional surgical interventions, favoring minimally invasive and regenerative techniques that accelerate recovery times and improve overall patient outcomes.

Innovative treatments such as autologous chondrocyte implantation and emerging microfracture procedures have set the stage for more sophisticated modalities in cartilage regeneration. Moreover, the integration of cell-based and scaffold-based techniques within tissue engineering has provided clinicians with enhanced tools to address complex cartilage injuries. As research continues to validate the efficacy of these novel approaches, there is a growing consensus that the shift towards biological regeneration is not merely an incremental improvement but a groundbreaking leap in the field.

The reconfiguration of treatment methodologies is also mirrored in market investments, regulatory reforms, and heightened patient expectations. This shifting paradigm compels industry stakeholders to embrace interdisciplinary collaborations and invest strategically in research and development, ensuring that innovative therapies can be efficiently adopted across clinical settings. The evolution in treatment practices underscores the transformative potential of modern approaches, driving the industry forward with renewed momentum and offering promising prospects for improved quality of life.

Key Segmentation Insights Driving Market Innovation

A close examination of market segmentation reveals the intricate layers that influence the cartilage repair and regeneration domain. The market is first categorized by repair techniques, ranging from Autologous Chondrocyte Implantation to Chondroplasty, Microfracture, Mosaicplasty, Osteochondral Autograft Transplantation, and the increasingly prominent Stem Cell-Based Cartilage Regeneration, which further distinguishes between Adult and Embryonic Stem Cells. Additionally, Tissue Engineering is subdivided into Cell-Based Techniques and Scaffold-Based Techniques, enabling a granular approach to understanding clinical interventions.

Further segmentation by targeted site illustrates that cartilage repair is tailored for specific anatomical regions such as the ankle, elbow, hip, knee, and shoulder, each with distinct physiological and biomechanical demands. Material type represents another critical segmentation parameter, distinguishing between Natural Biomaterials and Synthetic Biomaterials. Natural options like Chitosan-Based, Collagen-Based, and Hyaluronic Acid-Based materials are weighed alongside synthetic selections such as Polyethylene Glycol and Polylactic Acid, highlighting the balance between biocompatibility and functional durability.

Moreover, the market's segmentation on source type, differentiating between Allogeneic and Autologous sources, plays a crucial role in patient-specific treatment strategies. Applications are further delineated into Elastic Cartilage Repair, Fibrocartilage Repair, and Hyaline Cartilage Repair, underscoring the clinical specificity required for successful outcomes. Finally, end-user segmentation identifies the primary clientele including Ambulatory Surgical Centers, Hospitals, and Orthopedic Clinics, each influencing product development and market adoption strategies. These layered insights provide a foundation for targeted innovation and strategic planning within the complex ecosystem of cartilage repair.

Based on Repair Technique, market is studied across Autologous Chondrocyte Implantation (ACI), Chondroplasty, Microfracture, Mosaicplasty, Osteochondral Autograft Transplantation (OAT), Stem Cell-Based Cartilage Regeneration, and Tissue Engineering. The Stem Cell-Based Cartilage Regeneration is further studied across Adult Stem Cells and Embryonic Stem Cells. The Tissue Engineering is further studied across Cell-Based Techniques and Scaffold-Based Techniques.

Based on Targeted Site, market is studied across Ankle Cartilage, Elbow Cartilage, Hip Cartilage, Knee Cartilage, and Shoulder Cartilage.

Based on Material Type, market is studied across Natural Biomaterials and Synthetic Biomaterials. The Natural Biomaterials is further studied across Chitosan-Based, Collagen-Based, and Hyaluronic Acid-Based. The Synthetic Biomaterials is further studied across Polyethylene Glycol (PEG) and Polylactic Acid (PLA).

Based on Source Type, market is studied across Allogeneic and Autologous.

Based on Application, market is studied across Elastic Cartilage Repair, Fibrocartilage Repair, and Hyaline Cartilage Repair.

Based on End-Users, market is studied across Ambulatory Surgical Centers, Hospitals, and Orthopedic Clinics.

Comprehensive Regional Analysis of Cartilage Repair Markets

The global landscape for cartilage repair and regeneration is characterized by distinct regional nuances that shape market dynamics and strategic decisions. In the Americas, rapid technological adoption and robust healthcare infrastructure have propelled the integration of advanced regenerative techniques, establishing this region as a significant market driver. North America's emphasis on clinical research and patient-centric innovation further bolsters the sector, paving the way for both incremental and breakthrough improvements in treatment methodologies.

In Europe, the Middle East, and Africa, a combination of advanced regulatory frameworks and growing investment in healthcare technologies has facilitated the adoption of state-of-the-art cartilage repair solutions. Here, the emphasis on sustainable healthcare solutions and personalized treatment options is echoing across multiple markets, supported by both public and private sector initiatives that prioritize regenerative medicine.

Asia-Pacific, on the other hand, is rapidly emerging as a critical hub due to its expanding medical infrastructure, increasing patient awareness, and significant government initiatives in healthcare innovation. The region benefits from localized clinical expertise and a cost-effective production landscape, which together create a dynamic environment for the growth of regenerative therapies. Analyzing these regional trends reveals diverse growth catalysts and the potential for tailored market strategies that reflect local innovation, regulatory policies, and patient needs.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Notable Key Companies Shaping the Market Landscape

The market for cartilage repair continues to be influenced by a robust ecosystem of key industry players, each contributing a unique blend of clinical expertise, technological innovation, and strategic market positioning. Companies such as Anika Therapeutics Inc., Arthrex, Inc., and B. Braun SE are at the forefront, leveraging decades of expertise in developing advanced regenerative solutions. Dynamic initiatives spearheaded by organizations like BioTissue, Inc. and Bioventus have further brought state-of-the-art research to the clinical frontline.

Collaborations and technological advancements by Collagen Solutions Ltd., CollPlant Biotechnologies Ltd., and CONMED Corporation are enriching the innovation pipeline, addressing critical challenges through novel materials and biologically driven repair mechanisms. Pioneering companies such as Episurf Medical AB and Geistlich Pharma AG continue to drive market trends through investments in clinical trials and emerging technologies that redefine treatment protocols.

Esteemed industry leaders such as Integra LifeSciences Corporation, Isto Biologics Inc, and Johnson & Johnson Services, Inc. have established themselves as reliable partners in delivering transformative healthcare solutions. Contributions from Kolon TissueGene, Inc., MEDIPOST Co., Ltd., and Mesoblast Limited further underscore the market's commitment to superior regenerative therapies. With firms like Ocugen, Inc., Orthocell Ltd., and Regrow Biosciences Pvt Ltd. adding to the competitive momentum, combined with strategic activities by RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc., the industry is well-positioned to address future challenges while setting benchmarks for quality and innovation in cartilage repair.

The report delves into recent significant developments in the Cartilage Repair/Cartilage Regeneration Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics Inc., Arthrex, Inc., B. Braun SE, BioTissue, Inc., Bioventus, Collagen Solutions Ltd., CollPlant Biotechnologies Ltd., CONMED Corporation, Episurf Medical AB, Geistlich Pharma AG, Integra LifeSciences Corporation, Isto Biologics Inc, Johnson & Johnson Services, Inc., Kolon TissueGene, Inc., MEDIPOST Co., Ltd., Mesoblast Limited, Ocugen, Inc., Orthocell Ltd., Regrow Biosciences Pvt Ltd., RTI Surgical, Inc., Smith & Nephew PLC, Stryker Corporation, Vericel Corporation, and Zimmer Biomet Holdings, Inc.. Actionable Recommendations for Forward-Thinking Industry Leaders

For stakeholders aiming to secure a competitive advantage in the rapidly evolving field of cartilage repair and regeneration, it is imperative to embrace both short-term agility and long-term strategic planning. Industry leaders should prioritize increased investment in research and development, particularly in the realms of stem cell technology and tissue engineering, to maintain a robust innovation pipeline. Fostering collaborations across academic institutions, clinical research centers, and biotech firms can catalyze breakthroughs that address the intricacies of cellular regeneration and scaffold-based interventions.

Emphasis should also be placed on expanding regional presence to tap into emerging markets, especially in the Asia-Pacific region where dynamic growth is evident. Establishing localized partnerships and tailoring product offerings to meet regional demands can enhance market penetration and customer trust. Additionally, adapting to evolving regulatory landscapes and ensuring compliance with stringent standards will reinforce the credibility of therapeutic solutions while mitigating potential risks.

Furthermore, focus on developing strategic pricing models that balance affordability with advanced technological features is critical. Continuous engagement with clinicians at hospitals, ambulatory surgical centers, and specialized orthopedic clinics is essential to understand clinical needs and refine treatment protocols. By leveraging market segmentation insights and capitalizing on the diverse opportunities presented by targeted anatomical sites and material innovations, industry leaders can set new benchmarks in patient outcomes and commercial success.

Conclusion: Embracing the Future of Cartilage Regeneration

In conclusion, the evolving landscape of cartilage repair and regeneration reflects a blend of clinical innovation, strategic regional expansion, and robust industry collaboration. The transition from conventional repair techniques to advanced regenerative therapies is marked by significant progress in stem cell research, tissue engineering, and material innovation. This comprehensive analysis not only highlights the transformative shifts at the technological forefront but also underscores the importance of detailed segmentation and regional insights in shaping market strategies.

As the industry continues to mature, the ability to seamlessly integrate new technologies with established clinical practices will be crucial. The collective efforts of industry leaders, regulatory bodies, and research institutions will set the stage for a future where patient-centric, sustainable healthcare solutions are at the forefront of cartilage repair and regeneration.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of individuals participating in sports and physical activities
      • 5.1.1.2. Increasing the prevalence of degenerative joint diseases worldwide
      • 5.1.1.3. Rising awareness of cartilage-related conditions and improvements in diagnostic technology
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatments for cartilage repair and regeneration
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of 3D bioprinting technologies to create customized cartilage implants
      • 5.1.3.2. Supportive governments funding and incentives for research and development of advanced medical treatments
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of postoperative complications and long-term side effects associated with certain cartilage repair procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Repair Technique: Rising preference for autologous chondrocyte implantation for treating cartilage defects
    • 5.2.2. End-Users: Growing expansion in the fibrocartilage repair to address the menisci and intervertebral discs
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cartilage Repair/Cartilage Regeneration Market, by Repair Technique

  • 6.1. Introduction
  • 6.2. Autologous Chondrocyte Implantation (ACI)
  • 6.3. Chondroplasty
  • 6.4. Microfracture
  • 6.5. Mosaicplasty
  • 6.6. Osteochondral Autograft Transplantation (OAT)
  • 6.7. Stem Cell-Based Cartilage Regeneration
    • 6.7.1. Adult Stem Cells
    • 6.7.2. Embryonic Stem Cells
  • 6.8. Tissue Engineering
    • 6.8.1. Cell-Based Techniques
    • 6.8.2. Scaffold-Based Techniques

7. Cartilage Repair/Cartilage Regeneration Market, by Targeted Site

  • 7.1. Introduction
  • 7.2. Ankle Cartilage
  • 7.3. Elbow Cartilage
  • 7.4. Hip Cartilage
  • 7.5. Knee Cartilage
  • 7.6. Shoulder Cartilage

8. Cartilage Repair/Cartilage Regeneration Market, by Material Type

  • 8.1. Introduction
  • 8.2. Natural Biomaterials
    • 8.2.1. Chitosan-Based
    • 8.2.2. Collagen-Based
    • 8.2.3. Hyaluronic Acid-Based
  • 8.3. Synthetic Biomaterials
    • 8.3.1. Polyethylene Glycol (PEG)
    • 8.3.2. Polylactic Acid (PLA)

9. Cartilage Repair/Cartilage Regeneration Market, by Source Type

  • 9.1. Introduction
  • 9.2. Allogeneic
  • 9.3. Autologous

10. Cartilage Repair/Cartilage Regeneration Market, by Application

  • 10.1. Introduction
  • 10.2. Elastic Cartilage Repair
  • 10.3. Fibrocartilage Repair
  • 10.4. Hyaline Cartilage Repair

11. Cartilage Repair/Cartilage Regeneration Market, by End-Users

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Hospitals
  • 11.4. Orthopedic Clinics

12. Americas Cartilage Repair/Cartilage Regeneration Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Cartilage Repair/Cartilage Regeneration Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Cartilage Repair/Cartilage Regeneration Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. CO.DON GmbH leverages three decades of regenerative medicine expertise to drive advanced 3D bioprinting and cartilage repair innovations
    • 15.3.2. Faculty of Medicine at University of Helsinki launches transformative 3D bioprinting initiative to develop personalized bone and cartilage regeneration treatments
    • 15.3.3. CytexOrtho advances revolutionary cartilage repair with FDA-approved first-in-human trials for its ReNew Hip Implant
    • 15.3.4. Northwestern University pioneers future of cartilage regeneration and joint repair
    • 15.3.5. Altach secures EUR 1.2 million investment to revolutionize cartilage repair with innovative collagen scaffold
    • 15.3.6. Smith+Nephew's acquires CartiHeal to enhance their sports medicine portfolio
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anika Therapeutics Inc.
  • 2. Arthrex, Inc.
  • 3. B. Braun SE
  • 4. BioTissue, Inc.
  • 5. Bioventus
  • 6. Collagen Solutions Ltd.
  • 7. CollPlant Biotechnologies Ltd.
  • 8. CONMED Corporation
  • 9. Episurf Medical AB
  • 10. Geistlich Pharma AG
  • 11. Integra LifeSciences Corporation
  • 12. Isto Biologics Inc
  • 13. Johnson & Johnson Services, Inc.
  • 14. Kolon TissueGene, Inc.
  • 15. MEDIPOST Co., Ltd.
  • 16. Mesoblast Limited
  • 17. Ocugen, Inc.
  • 18. Orthocell Ltd.
  • 19. Regrow Biosciences Pvt Ltd.
  • 20. RTI Surgical, Inc.
  • 21. Smith & Nephew PLC
  • 22. Stryker Corporation
  • 23. Vericel Corporation
  • 24. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET MULTI-CURRENCY
  • FIGURE 2. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET MULTI-LANGUAGE
  • FIGURE 3. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET RESEARCH PROCESS
  • FIGURE 4. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET DYNAMICS
  • TABLE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AUTOLOGOUS CHONDROCYTE IMPLANTATION (ACI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MICROFRACTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MOSAICPLASTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY OSTEOCHONDRAL AUTOGRAFT TRANSPLANTATION (OAT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SCAFFOLD-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ANKLE CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ELBOW CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HIP CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY KNEE CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SHOULDER CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHITOSAN-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALURONIC ACID-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY POLYETHYLENE GLYCOL (PEG), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ELASTIC CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 62. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 69. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 70. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 71. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 72. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 73. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 79. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 80. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 81. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 82. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 83. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 89. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 90. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 91. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 92. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 93. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 95. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 106. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 122. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 124. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 128. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. AUSTRALIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 131. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 132. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 133. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 134. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 135. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 137. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 138. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. CHINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 141. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 143. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 144. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 145. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 147. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 148. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. INDIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 151. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 152. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 153. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 154. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 155. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 157. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 158. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. INDONESIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 161. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 162. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 163. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 164. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 165. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 167. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 168. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. JAPAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 172. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 174. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 177. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 178. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. MALAYSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 182. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 184. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 188. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. PHILIPPINES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 192. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 194. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 197. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 198. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SINGAPORE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH KOREA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 211. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 212. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 213. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 214. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 215. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 217. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 218. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. TAIWAN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 221. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 222. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 223. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 224. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 225. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 227. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 228. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. THAILAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 231. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 232. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 233. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 234. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 235. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 237. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 238. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. VIETNAM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 252. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 253. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 254. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 255. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 256. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 257. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 258. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 259. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 261. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 262. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 263. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 264. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 265. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
  • TABLE 266. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 268. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 269. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  • TABLE 272. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 273. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
  • TABLE 274. FINLAND CARTILAGE REPAIR/CAR